Analyst hikes Healthways price target

The fourth-quarter earnings and 2013 outlook provided the other day by Healthways executives have convinced Dougherty & Co. analyst Brooks O'Neil to lift his price target for the Franklin company. O'Neil, who has reiterated his 'buy' rating, now sees Healthways going to $16 instead of $12. Healthways (Ticker: HWAY) is changing hands this morning around $10.55.